Retatrutide

Retatrutide is a synthetic triple-receptor agonist studied for its effects on GLP-1, GIP, and glucagon pathways involved in energy regulation and metabolic homeostasis. Early clinical research shows predictable pharmacokinetics and dose-dependent exposure, while its safety and effectiveness remain under investigation.